At the EASL Congress 2024, Eli Lilly and Company presented positive results from the Phase II clinical trial, SYNERGY-NASH, of their tirzepatide for treating patients with biopsy-proven MASH with stage 2 or 3 fibrosis
In one of the largest trials of a GLP-1 tablet for weight loss, 667 participants adults with obesity or overweight (without diabetes) were observed
When a peptide arrives lyophilized (which is just a technical term for freeze-dried), its in its most stable state
[...] PSM statement on deeply concerning compounding of GLP-1 weight-loss pills PSM Executive Director Shabbir Imber Safdar released the following statement in response to news that Hims & Hers is now compounding pill versions of a newly approved GLP-1 weight-loss drug
See should copper peptides be refrigerated and GHK-Cu shelf life for product storage during cycling
Sources: Ozempic for weight loss: Does it work, and what do experts recommend